Insider buying
~$1.1K500 sh @ $2.26
Traded Dec 5, 2024 · filed 4 days later
The CEO of Impact Biomedical paid $1.1K out of pocket for Impact Biomedical shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 13, 2024 · Filed Nov 22, 2024
A major shareholder of Impact Biomedical sold $560 of Impact Biomedical shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$560
Shares × reported transaction price
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −6.3% | +1.0% | −7.3% |
| 30 days | −40.7% | +0.6% | −41.4% |
| 90 days | −21.5% | −0.1% | −21.4% |
| 180 days | −80.2% | −1.1% | −79.1% |
| 365 days | −83.8% | +13.0% | −96.8% |
Past results only. Not a forecast.
Insider buying
Traded Dec 5, 2024 · filed 4 days later
The CEO of Impact Biomedical paid $1.1K out of pocket for Impact Biomedical shares.
Insider buying
Traded Nov 26, 2024 · filed 8 days later
The CEO of Impact Biomedical paid $1.3K out of pocket for Impact Biomedical shares. It was the first purchase in over a year.
Insider buying
Traded Nov 27, 2024 · filed 7 days later
The CEO of Impact Biomedical paid $1.3K out of pocket for Impact Biomedical shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.